Contribution of Platelet CX 3 CR1 to Platelet–Monocyte Complex Formation and Vascular Recruitment During Hyperlipidemia
Author(s) -
Otilia Postea,
Elena M. Vasina,
Sandra Cauwenberghs,
Delia Projahn,
Elisa A. Liehn,
Dirk Lievens,
Wendy Theelen,
Birgit K. Kramp,
Elena Butoi,
Oliver Soehnlein,
Johan W. M. Heemskerk,
Andreas Ludwig,
Christian Weber,
Rory R. Koenen
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.243485
Subject(s) - platelet , monocyte , chemokine , platelet activation , medicine , chemistry , endocrinology , vascular smooth muscle , receptor , smooth muscle
The chemokine receptor CX(3)CR1 is an inflammatory mediator in vascular diseases. On platelets, its ligation with fractalkine (CX(3)CL1) induces platelet activation followed by leukocyte recruitment to activated endothelium. Here, we evaluated the expression and role of platelet-CX(3)CR1 during hyperlipidemia and vascular injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom